Linear Cognitive Aid for Pediatric Emergencies
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a new tool, called a linear cognitive aid, can improve emergency medical services (EMS) teams' responses during pediatric emergencies. Researchers seek to assess the tool's ease of use and effectiveness compared to current EMS methods. Teams will be randomly assigned to use either the new tool or their usual methods in managing simulated pediatric emergency situations. EMS providers who are actively working and understand English may qualify for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance emergency response for children.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this linear cognitive aid is safe for pediatric emergencies?
Research has shown that cognitive aids can enhance the performance and safety of emergency medical teams during high-pressure situations, such as emergencies involving children. Despite their potential benefits, many emergency teams do not widely use these aids.
The cognitive aid under study is a new tool designed to assist teams during children's resuscitations. As a tool, it does not carry safety risks like side effects or adverse reactions. The primary concern is whether it aids or confuses the medical teams using it.
This study focuses on the tool's ease of use and helpfulness for emergency teams, rather than testing its safety in the traditional sense. So far, no reports indicate the tool is unsafe. The main goal is to determine if it can make emergency responses more effective and less stressful for the teams involved.12345Why are researchers excited about this trial?
Researchers are excited about the Linear Cognitive Aid for pediatric emergencies because it offers a streamlined approach to handling critical situations involving children. Unlike the current standard, which often relies on various cognitive aids, this new method uses a linear, step-by-step guide to assist medical teams during high-pressure resuscitations. This structured approach could potentially improve decision-making speed and accuracy, ultimately leading to better outcomes for young patients in emergency settings.
What evidence suggests that this linear cognitive aid is effective for pediatric emergencies?
Research has shown that cognitive aids can enhance medical team performance during emergencies. These tools help teams adhere to guidelines more accurately and reduce errors. In this trial, one group will use a Linear Cognitive Aid, which presents information in a simple, step-by-step order, during high-fidelity simulations of pediatric emergencies. Another group will use the current standard of care with existing cognitive aids. One study found that using a cognitive aid helped teams adhere to resuscitation guidelines. This suggests that a straightforward cognitive aid could improve team performance in pediatric emergencies.678910
Are You a Good Fit for This Trial?
This trial is for Emergency Medical Services (EMS) teams who respond to pediatric emergencies involving cardiac arrest and other critical situations. It's designed to see if a new app, which provides step-by-step guidance during resuscitation, helps these teams.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Simulation
Participants perform in situ high-fidelity simulation of two critical children's resuscitation scenarios
Evaluation
Technical performance, teamwork, and cognitive load are evaluated
Follow-up
Participants are monitored for feedback on feasibility and acceptability of the cognitive aid
What Are the Treatments Tested in This Trial?
Interventions
- Linear Cognitive Aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator